RxDoctor Payments Data
★ My doctorsLook up a doctor →

Evgeniy Shchelchkov, MD

Neurology · Canonsburg, PANPI 1649276668

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,437 and has fallen 99.4% since, to $21 in 2021.

$5,149in general payments, 2019–2025

Across 295 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$560
  • Teva Pharmaceuticals USA, Inc.$501
  • Novartis$371
  • Lilly USA, LLC$334
  • Amgen$320
  • UCB, Inc.$320
  • plus $3K from 29 others

What the payments were for

  • Speaking & faculty fees$1964%
  • Food & beverage$4,95396%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie38$560
Teva Pharmaceuticals USA, Inc.19$501
Novartis32$371
Lilly USA, LLC17$334
Amgen6$320
UCB, Inc.20$320
Acorda Therapeutics, Inc14$308
Genentech USA, Inc.10$241
Biogen11$208
Sanofi10$189
Neurocrine Biosciences, Inc.11$182
Supernus Pharmaceuticals, Inc.15$173
Amneal Pharmaceuticals LLC10$167
Avanir Pharmaceuticals, Inc.10$154
Acadia Pharmaceuticals Inc8$147
EMD Serono, Inc.7$130
MDD US Operations, LLC8$120
Vertical Pharmaceuticals, LLC6$104
Adamas Pharmaceuticals, Inc.5$81
Bausch Health US, LLC4$71
Sunovion Pharmaceuticals Inc.7$66
Arbor Pharmaceuticals, Inc.4$50
GE HealthCare4$50
Assertio Therapeutics, Inc.3$45
Jazz Pharmaceuticals Inc.2$37
Livanova USA, Inc.2$33
Pfizer2$32
Kyowa Kirin, Inc.2$29
AstraZeneca2$27
Greenwich Biosciences, Inc.1$18
Grifols USA, LLC1$18
Upsher-smith Laboratories LLC1$17
Scilex Pharmaceuticals Inc.1$16
SK Life Science, Inc.1$16
Currax Pharmaceuticals LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,149 in reported general payments places this provider in the 70th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$55,253
Medicare patients
329
Services billed
652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Canonsburg

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →